SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Ontology highlight
ABSTRACT: Alternative splicing (AS) occurs in nearly all human genes and abnormal AS has a close association with cancer. Serine and arginine‑rich splicing factor 6 (SRSF6), a canonical member of the serine/arginine‑rich protein family, has been characterized as an important regulator of AS. However, the role of SRSF6 in regulating AS in cancers has remained to be fully elucidated. In the present study, the median expression of SRSF6 in tumors was determined to be higher compared with that in matched normal tissues in 13 out of 16 cancer types from The Cancer Genome Atlas. To investigate the biological effects of SRSF6 overexpression, an SRSF6‑overexpression model of HeLa cells was constructed and it was revealed that SRSF6 overexpression resulted in significantly higher apoptosis and lower prolifer
SUBMITTER: Yang X
PROVIDER: S-EPMC7551351 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA